摘要
目的:探讨超早期及早期颈动脉加压滴注抗凝溶栓剂降纤酶治疗急性脑梗死的临床疗效。方法:颈动脉治疗组用降纤酶颈动脉内加压滴注二疗程共12d;对照组静脉滴注降纤酶,疗程同治疗组。结果:治疗组总显效率93.5％,对照组为66.7％(P<0.01)。治疗组治疗后神经功能缺损积分减少与对照组比较差异显著(P<0.01),且发病距用药时间与疗效呈正相关,时间越短,神经功能恢复越快。结论:超早期及早期颈动脉内应用降纤酶治疗急性脑梗死疗效较好。
Objective: To study clinical therapeautic effect of suppe- early and early internal carotid artery increase pressure adminstration anticoagulation thrombolytic dose defibrase therapy in acute brain infarction. Methods: Intracarotid artery treatment group defibrase internal carotid artery administration by increased pressure two peroid 12 days; control group intravenous administration defibrase similar to treatment group at peroid. Results: Treatment group total marked effect rate was 93.5%, control group 66.1% (P<0.01), After treatment, treatment group neuralogic defictits score decrease between the two group had significant differences (P<0.01) ; ill to use drugs time with therapy effect had positive correlation. Shorter time, faster neurologic fuction recovery. Conlusions: Supper - early and early intracarotid artery administration defibrase in acute brain infarction had better therapy effect.
出处
《黔南民族医专学报》
2003年第1期15-17,共3页
Journal of Qiannan Medical College for Nationalities
关键词
超早期
脑梗死
颈动脉
注射
动脉内
降纤酶
super - early peorid
brain infarction
carotic
artery
defibrase
